Baxter Pharmaceuticals India Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Village Vasana-Chacharwadi, Taluka Sanand, Ahmedabad, Gujarat 382213, India (IND)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3004610460 · DUNS 918603338
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2023-01-27
- VAIDrug Quality Assurance2022-05-17
- OAIDrug Quality Assurance2017-08-04
- VAIDrug Quality Assurance2016-08-26
- VAIDrug Quality Assurance2015-05-11
- VAIDrug Quality Assurance2013-10-18
- VAIDrug Quality Assurance2012-03-02
- OAIDrug Quality Assurance2010-06-16
- VAIDrug Quality Assurance2009-11-12
Drugs this plant is listed as making
8 distinct drugs across 18 products name this site in their FDA label.
- FlumazenilBaxter Healthcare Corporation
- furosemidein shortageBaxter Healthcare Corporation
- levofloxacinBaxter Healthcare Corporation
- metoprolol tartrateBaxter Healthcare Corporation
- Ondansetron HydrochlorideBaxter Healthcare Corporation
- phenylephrine hydrochlorideBaxter Healthcare Corporation
- SumatriptanBaxter Healthcare Corporation
- TobramycinBaxter Healthcare Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.